BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1211 related articles for article (PubMed ID: 8530330)

  • 1. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary observations of DSM-III-R axis I comorbidity in men with paraphilias and paraphilia-related disorders.
    Kafka MP; Prentky RA
    J Clin Psychiatry; 1994 Nov; 55(11):481-7. PubMed ID: 7989281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety disorders in adults treated by hemodialysis: a single-center study.
    Cukor D; Coplan J; Brown C; Friedman S; Newville H; Safier M; Spielman LA; Peterson RA; Kimmel PL
    Am J Kidney Dis; 2008 Jul; 52(1):128-36. PubMed ID: 18440682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antisocial personality disorder and substance disorder morbidity in a clinical sample.
    Westermeyer J; Thuras P
    Am J Drug Alcohol Abuse; 2005; 31(1):93-110. PubMed ID: 15768573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
    Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
    J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity of axis I psychiatric disorders in bulimia nervosa.
    Brewerton TD; Lydiard RB; Herzog DB; Brotman AW; O'Neil PM; Ballenger JC
    J Clin Psychiatry; 1995 Feb; 56(2):77-80. PubMed ID: 7852257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in adults with intellectual disability: symptoms and challenging behaviour.
    Hurley AD
    J Intellect Disabil Res; 2008 Nov; 52(11):905-16. PubMed ID: 18680532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between depression and anxiety in dystonic patients: implications for clinical management.
    Moraru E; Schnider P; Wimmer A; Wenzel T; Birner P; Griengl H; Auff E
    Depress Anxiety; 2002; 16(3):100-3. PubMed ID: 12415533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety disorders among patients with co-occurring bipolar and substance use disorders.
    Kolodziej ME; Griffin ML; Najavits LM; Otto MW; Greenfield SF; Weiss RD
    Drug Alcohol Depend; 2005 Nov; 80(2):251-7. PubMed ID: 15876498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    Graystone HJ; Garner MJ; Baldwin DS
    J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders.
    Bizzarri JV; Rucci P; Sbrana A; Gonnelli C; Massei GJ; Ravani L; Girelli M; Dell'osso L; Cassano GB
    Addict Behav; 2007 Feb; 32(2):384-91. PubMed ID: 16797139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.